BVNKF
Price
$36.01
Change
-$0.29 (-0.80%)
Updated
Oct 7 closing price
Capitalization
2.35B
Intraday BUY SELL Signals
MBXBF
Price
$0.18
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
Capitalization
22.33M
Intraday BUY SELL Signals
Interact to see
Advertisement

BVNKF vs MBXBF

Header iconBVNKF vs MBXBF Comparison
Open Charts BVNKF vs MBXBFBanner chart's image
Bavarian Nordic A/S
Price$36.01
Change-$0.29 (-0.80%)
Volume$223
Capitalization2.35B
Microbix Biosystems
Price$0.18
Change-$0.00 (-0.00%)
Volume$97K
Capitalization22.33M
BVNKF vs MBXBF Comparison Chart in %
BVNKF
Daily Signal:
Gain/Loss:
MBXBF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BVNKF vs. MBXBF commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVNKF is a Hold and MBXBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (BVNKF: $29.50 vs. MBXBF: $0.16)
Brand notoriety: BVNKF and MBXBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVNKF: 165% vs. MBXBF: 135%
Market capitalization -- BVNKF: $2.35B vs. MBXBF: $22.33M
BVNKF [@Biotechnology] is valued at $2.35B. MBXBF’s [@Biotechnology] market capitalization is $22.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVNKF’s FA Score shows that 0 FA rating(s) are green whileMBXBF’s FA Score has 1 green FA rating(s).

  • BVNKF’s FA Score: 0 green, 5 red.
  • MBXBF’s FA Score: 1 green, 4 red.
According to our system of comparison, BVNKF is a better buy in the long-term than MBXBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVNKF’s TA Score shows that 5 TA indicator(s) are bullish while MBXBF’s TA Score has 4 bullish TA indicator(s).

  • BVNKF’s TA Score: 5 bullish, 1 bearish.
  • MBXBF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BVNKF is a better buy in the short-term than MBXBF.

Price Growth

BVNKF (@Biotechnology) experienced а 0.00% price change this week, while MBXBF (@Biotechnology) price change was -0.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BVNKF($2.35B) has a higher market cap than MBXBF($22.3M). MBXBF has higher P/E ratio than BVNKF: MBXBF (22.17) vs BVNKF (6.08). BVNKF YTD gains are higher at: 0.000 vs. MBXBF (-9.041). BVNKF has higher annual earnings (EBITDA): 3.21B vs. MBXBF (2.47M). BVNKF has more cash in the bank: 2.98B vs. MBXBF (12.1M). MBXBF has less debt than BVNKF: MBXBF (6.41M) vs BVNKF (134M). BVNKF has higher revenues than MBXBF: BVNKF (6.89B) vs MBXBF (21.1M).
BVNKFMBXBFBVNKF / MBXBF
Capitalization2.35B22.3M10,534%
EBITDA3.21B2.47M129,798%
Gain YTD0.000-9.041-
P/E Ratio6.0822.1727%
Revenue6.89B21.1M32,640%
Total Cash2.98B12.1M24,612%
Total Debt134M6.41M2,092%
FUNDAMENTALS RATINGS
BVNKF vs MBXBF: Fundamental Ratings
BVNKF
MBXBF
OUTLOOK RATING
1..100
4975
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4590
PRICE GROWTH RATING
1..100
6384
P/E GROWTH RATING
1..100
957
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BVNKF's Valuation (48) in the null industry is in the same range as MBXBF (78). This means that BVNKF’s stock grew similarly to MBXBF’s over the last 12 months.

BVNKF's Profit vs Risk Rating (100) in the null industry is in the same range as MBXBF (100). This means that BVNKF’s stock grew similarly to MBXBF’s over the last 12 months.

BVNKF's SMR Rating (45) in the null industry is somewhat better than the same rating for MBXBF (90). This means that BVNKF’s stock grew somewhat faster than MBXBF’s over the last 12 months.

BVNKF's Price Growth Rating (63) in the null industry is in the same range as MBXBF (84). This means that BVNKF’s stock grew similarly to MBXBF’s over the last 12 months.

MBXBF's P/E Growth Rating (7) in the null industry is significantly better than the same rating for BVNKF (95). This means that MBXBF’s stock grew significantly faster than BVNKF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BVNKFMBXBF
RSI
ODDS (%)
Bullish Trend 6 days ago
47%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
49%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
41%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
46%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
36%
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BVNKF
Daily Signal:
Gain/Loss:
MBXBF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNAF7.970.21
+2.65%
Commercial National Financial Corp. (PA)
BZZUY29.85N/A
N/A
Buzzi SpA
PWFNF16.03N/A
N/A
Power Financial Corp.
IRLCF238.00N/A
N/A
Israel Corp.
TGDLF0.48N/A
N/A
TONGDAO LIEPIN GROUP

BVNKF and

Correlation & Price change

A.I.dvisor tells us that BVNKF and LABFF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVNKF and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVNKF
1D Price
Change %
BVNKF100%
N/A
LABFF - BVNKF
24%
Poorly correlated
N/A
SILO - BVNKF
22%
Poorly correlated
-2.39%
GOVX - BVNKF
22%
Poorly correlated
-6.07%
MBXBF - BVNKF
21%
Poorly correlated
N/A
IMRN - BVNKF
20%
Poorly correlated
-6.61%
More

MBXBF and

Correlation & Price change

A.I.dvisor tells us that MBXBF and CRMD have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBXBF and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBXBF
1D Price
Change %
MBXBF100%
N/A
CRMD - MBXBF
27%
Poorly correlated
-0.61%
TECX - MBXBF
23%
Poorly correlated
+1.87%
BVNKF - MBXBF
21%
Poorly correlated
N/A
NBY - MBXBF
20%
Poorly correlated
-32.16%
MMIRF - MBXBF
15%
Poorly correlated
N/A
More